Effect of cardiac resynchronization therapy on thyroid function

Clinical Cardiology

Volumn 34, Issue 11, 2011, Pages 703-705

  Celikyurt, Umut ^a   Agacdiken, Aysen ^a   Geyik, Bilal ^b   Kozdag, Guliz ^a   Vural, Ahmet ^a   Ural, Dilek ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; STROKE VOLUME; THYROID FUNCTION TESTS; THYROID GLAND; THYROTROPIN; THYROXINE; TIME FACTORS; TREATMENT OUTCOME; TRIIODOTHYRONINE; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 81555208658     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20952     Document Type: Article

References (16)

1. Landolina M, Lunati M, Gasparini M, et al. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry). Am J Cardiol. 2007; 100: 1007-1012. (Pubitemid 47371226)
2. Klein I, Danzi S., Thyroid disease and the heart. Circulation. 2007; 116: 1725-1735. (Pubitemid 47537847)
3. Iervasi G, Pingitore A, Landi P, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003; 107: 708-713. (Pubitemid 36222598)
4. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989; 2: 358-367.
5. Utiger RD., Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat? N Engl J Med. 1995; 333: 1562-1563.
6. Chopra IJ., Clinical review 86: Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab. 1997; 82: 329-334.
7. Kozdag G, Ural D, Vural A, et al. Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy. Eur J Heart Fail. 2005; 7: 113-118. (Pubitemid 40092502)
8. Kimura T, Kanda T, Kotajima N, et al. Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction. Eur J Endocrinol. 2000; 143: 179-184. (Pubitemid 30622350)
9. Girvent M, Maestro S, Hernandez R, et al. Euthyroid sick syndrome, associated endocrine abnormalities, and outcome in elderly patients undergoing emergency operation. Surgery. 1998; 123: 560-567. (Pubitemid 28215369)
10. Bhatia V, Bhatia R, Dhindsa S, et al. Cardiac resynchronization therapy in heart failure: recent advances and new insights. Indian Pacing Electrophysiol J. 2006; 3: 129-142.
11. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002; 40: 111-118. (Pubitemid 34701385)
12. Calvo-Romero JM, Rodriguez EM., Serum-free thyroxine and thyrotropin concentrations in euthyroid patients with decompensated congestive heart failure. Int J Cardiol. 2005; 102: 367-368. (Pubitemid 40854062)
13. Silva-Tinoco R, Castillo-Martinez L, Orea-Tejeda A, et al. Developing thyroid disorders is associated with poor prognosis factors in patient with stable chronic heart failure. Int J Cardiol. 2011; 147: e24-e25.
14. Forini F, Paolicchi A, Pizzorusso T, et al. 3,5,3′ -Triiodothyronine deprivation affects phenotype and intracellular [Ca2+]i of human cardiomyocytes in culture. Cardiovasc Res. 2001; 51: 322-330. (Pubitemid 32695543)
15. Pantos C, Mourouzis I, Cokkinos DV., New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider? Heart Fail Rev. 2011; 16: 79-96.
16. Pantos C, Mourouzis I, Markakis K, et al. Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats. Eur J Cardiothorac Surg. 2007; 2: 333-339. (Pubitemid 47021454)